Picture of Rhinomed logo

RNO Rhinomed Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Rhinomed, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2019
June 30th
2020
June 30th
C2021
June 30th
2022
June 30th
2023
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital0.0850.6350.5390.4270.642
Other Operating Cash Flow
Cash from Operating Activities-4.49-5.74-5.22-5.74-7.18
Capital Expenditures-0.231-0.011-0.049-0.877-0.095
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.0350.006
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-0.266-0.005-0.049-0.877-0.095
Financing Cash Flow Items-0.218-0.465-0.022-0.2630
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities4.8812-0.146.255.46
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.1586.34-5.42-0.355-1.79